✦ LIBER ✦

A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study

✍ Scribed by Philippe A. Cassier; Sylvie Chabaud; Véronique Trillet-Lenoir; Pierre-Yves Peaud; Jean-Dominique Tigaud; Hervé Cure; Hubert Orfeuvre; Bruno Salles; Claude Martin; Jean-Philippe Jacquin; Cecile Agostini; Jean-Paul Guastalla; David Pérol; Thomas Bachelot

Publisher: Springer US
Year: 2007
Tongue: English
Weight: 233 KB
Volume: 109
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-007-9651-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taxane vs. taxane: is the duel at an end

Taxane vs. taxane: is the duel at an end? A commentary on a phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study

✍ Sofyan M. Radaideh; George W. Sledge 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 174 KB

Non-pegylated liposomal doxorubicin and

Non-pegylated liposomal doxorubicin and docetaxel in metastatic breast cancer: final results of a phase

✍ Peter Schmid; J. Krocker; R. Kreienberg; P. Klare; K. Kittel; H. Sommer; G. Hein 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 246 KB

Phase II trial of doxorubicin and triflu

Phase II trial of doxorubicin and trifluoperazine in metastatic breast cancer

✍ G. T. Budd; R. M. Bukowski; A. Lichtin; L. Bauer; P. Kirk; R. Ganapathi 📂 Article 📅 1993 🏛 Springer US 🌐 English ⚖ 361 KB

Phase II trial of pegylated liposomal do

Phase II trial of pegylated liposomal doxorubicin plus docetaxel with and without trastuzumab in metastatic breast cancer: Eastern Cooperative Oncology Group Trial E3198

✍ Antonio C. Wolff; Molin Wang; Hailun Li; Michael R. Pins; Florence J. Pretorius; 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 311 KB

Methotrexate, vinblastine, doxorubicin,

Methotrexate, vinblastine, doxorubicin, and cisplatin in metastatic breast cancer. A phase II trial of the hoosier oncology group

✍ Bruce J. Roth; George W. Sledge Jr; Stephen D. Williams; Steven C. Meyer; Rafat 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 490 KB 👁 2 views

Forty-six eligible patients with metastatic breast cancer (MBC) were treated with a combination of methotrexate, vinblastine, doxorubicin, and cisplatin (M-VAC) as first-line chemotherapy. Of 44 patients evaluable for response, 28 (64%) had an objective response, including seven (16%) who had a comp

Primary chemotherapy with doxorubicin an

Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study

✍ P. Schmid; J. Krocker; G. Morack; V. Heilmann; J.-U. Blohmer; K. Michniewicz; G. 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 198 KB